Thal/Dex regimen: Difference between revisions

	WikiDoc Resources for Thal/Dex regimen
Articles
Most recent articles on Thal/Dex regimen Most cited articles on Thal/Dex regimen Review articles on Thal/Dex regimen Articles on Thal/Dex regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Thal/Dex regimen Images of Thal/Dex regimen Photos of Thal/Dex regimen Podcasts & MP3s on Thal/Dex regimen Videos on Thal/Dex regimen
Evidence Based Medicine
Cochrane Collaboration on Thal/Dex regimen Bandolier on Thal/Dex regimen TRIP on Thal/Dex regimen
Clinical Trials
Ongoing Trials on Thal/Dex regimen at Clinical Trials.gov Trial results on Thal/Dex regimen Clinical Trials on Thal/Dex regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Thal/Dex regimen NICE Guidance on Thal/Dex regimen NHS PRODIGY Guidance FDA on Thal/Dex regimen CDC on Thal/Dex regimen
Books
Books on Thal/Dex regimen
News
Thal/Dex regimen in the news Be alerted to news on Thal/Dex regimen News trends on Thal/Dex regimen
Commentary
Blogs on Thal/Dex regimen
Definitions
Definitions of Thal/Dex regimen
Patient Resources / Community
Patient resources on Thal/Dex regimen Discussion groups on Thal/Dex regimen Patient Handouts on Thal/Dex regimen Directions to Hospitals Treating Thal/Dex regimen Risk calculators and risk factors for Thal/Dex regimen
Healthcare Provider Resources
Symptoms of Thal/Dex regimen Causes & Risk Factors for Thal/Dex regimen Diagnostic studies for Thal/Dex regimen Treatment of Thal/Dex regimen
Continuing Medical Education (CME)
CME Programs on Thal/Dex regimen
International
Thal/Dex regimen en Espanol Thal/Dex regimen en Francais
Business
Thal/Dex regimen in the Marketplace Patents on Thal/Dex regimen
Experimental / Informatics
List of terms related to Thal/Dex regimen

VisualWikitext

Latest revision as of 15:16, 30 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Thalidomide-Dexamethasone Regimen

Overview

Thal/Dex regimen refers to a regimen consisting of thalidomide and dexamethasone used for the treatment for multiple myeloma.^[1]^[2]

Regimen

ThalThalidomide

DexDexamethasone

Indications

Multiple myeloma^[1]

References

↑ ^1.0 ^1.1 Zamagni E, Petrucci A, Tosi P, Tacchetti P, Perrone G, Brioli A; et al. (2012). "Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma". Ann Hematol. 91 (3): 419–26. doi:10.1007/s00277-011-1320-2. PMID 21901342.
↑ "NCI Thesaurus".

[pmid21901342-1] 1.0 ^1.1 Zamagni E, Petrucci A, Tosi P, Tacchetti P, Perrone G, Brioli A; et al. (2012). "Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma". Ann Hematol. 91 (3): 419–26. doi:10.1007/s00277-011-1320-2. PMID 21901342.

[2] "NCI Thesaurus".

[1]

[2]

@@ Line 10: / Line 10: @@
 ==Regimen==
 {{chemo|Thal|Thalidomide}}
 {{chemo|Dex|Dexamethasone}}
 ==Indications==
 *[[Multiple myeloma]]<ref name="pmid21901342">{{cite journal| author=Zamagni E, Petrucci A, Tosi P, Tacchetti P, Perrone G, Brioli A et al.| title=Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. | journal=Ann Hematol | year= 2012 | volume= 91 | issue= 3 | pages= 419-26 | pmid=21901342 | doi=10.1007/s00277-011-1320-2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21901342 }} </ref>
 ==References==
 {{Reflist|2}}
 [[Category:Chemotherapy regimens]]